The Genomic Era:
In recent years, genomic diagnostic and screening tests have been able to accurately identify targeted treatments for cancer patients.
The tests lay the foundation for precision medicine, also called personalised or targeted medicine.
As a bonus: pharmacogenomic tests can determine whether the patient can metabolise (digest/absorb) the identified target treatment successfully.
These two tests have revolutionised cancer medicine with targeted treatments achieving better outcomes with minimal side effects.
Despite recent advances, the outdated one size fits all model is still common in conventional medicine as well as complementary & alternative cancer medicines.
One size fits all approaches are commonplace in…
Our hospitals – this is the Gold Standard of Cancer Care. Hospitals are limited by finances and hospital/insurance company protocols)
Supplements, super-foods or extreme diet approaches – the outdated assumption that certain diet regimes are good for all cancer patients.
Any generic advice from Dr Google, family, friends, workmates is by nature, one size fits all, and may do more harm than good, can cause cancer.
From Genome Mag – “Most often today, your treatment plan isn’t about you specifically.
It’s what doctors would give to anyone with the same condition — your neighbour, the hot dog vendor, or the prime minister of Bangladesh.
Most cancer medicine revolves around “standards of care,” that is providing the best courses of prevention or treatment for the average person on the street.
With breast cancer, for example, those standards mean self-exams and mammograms after a set age and the usual chemotherapy, surgery to treat a tumour if one is found.
If the first treatment doesn’t work, doctors and patients move on to the next one and the next. It’s trial and error, with life on the line.
But each cancer in each person has its own genetic makeup – each tumour is a unique character with unique tendencies and vulnerabilities.
In some cases, the current standard of care may be the safest, most sensible option, but it’s also one size fits all.
Sometimes that’s sufficient, but not always.”
Don't miss out on the biggest breakthroughs in cancer medicine for decades. The following videos explain cancer genomics in layman's terms..
A bad deal for Australian Patients
As you can see, countries like Australia or New Zealand lag behind other OECD countries.
Via our global cancer navigation service, we can often access these medicines for our patients once they are approved overseas – sometimes this can be many years before available in Australia for example.
As well, we can help our patients access precision or personalised medicine built around genomic and pharmaco-genomic tests.
Our testimonial page (orange button below) features 10 quite remarkable patient stories – all were recipients of precision or personalised medicine.